Actively Recruiting
RT-CGM in Young Adults at Risk of DKA
Led by Imperial College London · Updated on 2022-06-24
20
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
Sponsors
I
Imperial College London
Lead Sponsor
D
DexCom, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pilot study to evaluate the effect of real time continuous glucose monitoring (RT-CGM) on young-adults with insulin-treated diabetes, who are defined as high risk due to suboptimal HbA1c (blood glucose control) or a history of hospital admissions for high blood glucoses. Hypothesis: RT-CGM provided to young adults with suboptimal blood glucose control, has a beneficial impact on HbA1c and hospital admissions for high blood glucoses. We will use data from this pilot work to inform a larger powered study to address this knowledge gap.
CONDITIONS
Official Title
RT-CGM in Young Adults at Risk of DKA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adolescents and young adults aged 18-25 years
- Insulin-treated diabetes for more than 12 months using multiple daily injections or insulin pump therapy
- HbA1c greater than 75 mmol/mol (9%) or at least one diabetic ketoacidosis admission or one admission for uncontrolled blood glucose in the last 12 months
- No prior long-term use of real-time continuous glucose monitoring except short diagnostic or monitoring use
- Prior use of flash glucose monitoring is allowed
You will not qualify if you...
- Chronic kidney disease with eGFR less than 30 ml/min
- Pregnant or planning pregnancy
- Breastfeeding
- Active malignancy or under investigation for cancer
- Severe visual impairment
- Reduced manual dexterity
- Unable to participate due to other factors as determined by the Chief Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Imperial College Clinical Research Facility
London, United Kingdom
Actively Recruiting
Research Team
S
Shivani Misra
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here